Wenbiao Chen
-
Early research shows promise for therapeutics that delay Type 2 Diabetes
Discovering the mechanism behind cell behavior that is a hallmark of type 2 diabetes, Vanderbilt researchers move closer to treatments for the disease, which affects 34 million Americans. Read MoreJan 12, 2021
-
Vanderbilt researchers develop publicly available COVID-19 animal susceptibility prediction tool; suggests increased risk to horses
All-remote collaboration results in free animal susceptibility tool to help prioritize research and closer examination of at-risk species. Read MoreOct 6, 2020
-
Fighting type 2 diabetes with FGF1
The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes. Read MoreNov 18, 2015
-
In a zebrafish’s eye
Vanderbilt investigators demonstrate that a certain eye lens protein is evolutionarily conserved between zebrafish and rat, suggesting that zebrafish can be used as a model system to understand eye lens disorders such as cataracts. Read MoreJul 29, 2015
-
A “CRISPR” way to study disease
Using revolutionary CRISPR technology, Vanderbilt investigators have developed a fast and simple method to simultaneously turn off multiple genes in order to study complex diseases. Read MoreJun 11, 2015
-
Tiny model of diabetes
Vanderbilt University researchers have created a zebrafish model of skeletal muscle insulin resistance that could help improve diabetes treatment. Read MoreFeb 20, 2015
-
Setting traps to probe gene function
A new method for creating genetic mutations that can be activated at certain times or in specific tissues will enable studies to probe gene function. Read MoreOct 18, 2012